Franklin Resources
GBT

Franklin Resources’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Franklin Resources’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-469,444
Closed -$15M – 2443
2022
Q2 		$15M Sell
469,444
-137,882
-23% -$4.04M 0.01% 862
2022
Q1 		$21M Sell
607,326
-3,584
-0.6% -$107K 0.01% 846
2021
Q4 		$17.9M Sell
610,910
-1,078,219
-64% -$33.4M 0.01% 923
2021
Q3 		$43M Sell
1,689,129
-566,863
-25% -$16.7M 0.02% 696
2021
Q2 		$79M Buy
2,255,992
+65,147
+3% +$2.54M 0.03% 519
2021
Q1 		$89.3M Buy
2,190,845
+883
+0% +$40.6K 0.04% 461
2020
Q4 		$94.8M Buy
2,189,962
+262,925
+14% +$13M 0.04% 441
2020
Q3 		$106M Buy
1,927,037
+677,250
+54% +$43M 0.05% 366
2020
Q2 		$90.1M Buy
1,249,787
+284,628
+29% +$19.5M 0.05% 401
2020
Q1 		$49.3M Sell
965,159
-121,117
-11% -$8.11M 0.03% 466
2019
Q4 		$86.3M Sell
1,086,276
-404,586
-27% -$24M 0.05% 412
2019
Q3 		$72.3M Buy
1,490,862
+78,553
+6% +$4.09M 0.04% 450
2019
Q2 		$74.3M Buy
1,412,309
+704,956
+100% +$40.5M 0.04% 457
2019
Q1 		$37.4M Buy
707,353
+8
+0% +$393 0.02% 588
2018
Q4 		$29M Sell
707,345
-155,463
-18% -$5.83M 0.02% 616
2018
Q3 		$32.8M Buy
862,808
+123,179
+17% +$5.46M 0.02% 644
2018
Q2 		$33.4M Buy
739,629
+118,029
+19% +$5.37M 0.02% 636
2018
Q1 		$30M Buy
+621,600
New +$34.7M 0.02% 673

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources's GBT Position: Q3 2022 in Review

Franklin Resources sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 469,444 shares — an estimated $15M sold.

Franklin Resources first reported a position in GBT in Q1 2018 and held it in 18 quarters. The position peaked at $106M in Q3 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Franklin Resources reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Franklin Resources sold 469,444 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $15M.
  • Franklin Resources first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 18 quarters.
  • Franklin Resources's Global Blood Therapeutics, Inc. position peaked at $106M in Q3 2020.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.